Evidence map›Paper›PMID 40510080›Full record

ArticleCureus2025

Relevance of the International Study Group of Pancreatic Surgery and the Dutch Pancreatic Cancer Group Classifications of Pancreas-Specific Risk Factors in Predicting Clinically Relevant Postoperative Pancreatic Fistula in the Whipple Procedure.

Saurav Karki, Bishnu Kandel, Deepak Sharma, Nishnata Koirala, Paleswan Joshi Lakhey

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saurav KarkiDepartment of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NPL.
Bishnu KandelDepartment of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NPL.
Deepak SharmaDepartment of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NPL.
Nishnata KoiralaDepartment of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NPL.
Paleswan Joshi LakheyDepartment of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NPL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The International Study Group of Pancreatic Surgery (ISGPS)introduced a four-tier classification system, including pancreatic texture and pancreatic duct diameter, to aid the risk stratification of clinically relevant postoperative pancreatic fistula. The Dutch Pancreatic Cancer Group (DPCG) validated the ISGPS risk classification and proposed a three-tier classification system. This study was conducted to compare the clinically relevant postoperative pancreatic fistula rate among two classification systems. Methods This study was conducted by a retrospective review of the prospectively maintained data of 165 patients who underwent pancreaticoduodenectomy, also known as the Whipple Procedure, between 2015 and 2024 in a single unit of the Department of Surgical Gastroenterology at Tribhuvan University Teaching Hospital, Kathmandu, Nepal. The preoperative, intraoperative, and postoperative variables were analyzed to assess the relevance of the two classifications to predict clinically relevant postoperative pancreatic fistula. Results Ampullary carcinoma was the most common indication of pancreaticoduodenectomy (47.3%, n=78). Fifty patients (30.3%) had a main pancreatic duct diameter ≤3 mm, and 62.4% (n=103) had soft pancreatic texture. Twenty-eight patients (17.0%) developed clinically relevant postoperative pancreatic fistula, 44 (26.7%) had major complications (Clavien Dindo ≥3), and in-hospital mortality was seen in 13 (7.9%). Main pancreatic duct diameter ≤3 mm (36.0% vs 8.7%, P: <0.001), blood loss ≥500 ml (21.4% vs 7.5%, P: 0.027), and non-pancreatic pathology (21.5% vs 4.5%, P: 0.010) were significantly associated with clinically relevant postoperative pancreatic fistula but main pancreatic duct diameter ≤3 mm (OR: 7.313, P: 0.007, 95%CI: 1.462-12.124) was the only independent predictor. The rate of clinically relevant postoperative pancreatic fistula was significantly different in the subclasses in both the ISGPS and the DPCG classifications, being highest in Type D (40.5%, n=17). Both the classification systems showed similar predictivity for clinically relevant postoperative pancreatic fistula, with similar area under the curve, 0.707 for the ISGPS classification and 0.710 for the DPCG classification. Conclusion This study showed that the Type D (as per the ISGPS classification) or the two-risk-factor group (as per the DPCG classification) has the highest rate of postoperative complications after pancreaticoduodenectomy. On further analysis of the classification of pancreas-specific risk factors, including pancreatic texture and main pancreatic duct diameter, according to the ISGPS and DPCG classification systems, predictive accuracy was similar for clinically relevant postoperative pancreatic fistula; however, the DPCG classification with the simpler three-tier system is easier to apply in practice.

Indexed as

clinically-relevant postoperative pancreatic fistuladutch 3 tier classificationisgps classificationmain pancreatic duct diameterpancreas specific risk factorspancreaticoduodenectomypost operative pancreatic fistulasoft pancreas

Identifiers

PMID40510080
PMCPMC12162143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.